Glutathione synthetase deficiency is an autosomal recessive disorder that was first diagnosed in 1970 in a teenager with a slowly progressive neurologic disorder and markedly elevated excretion of 5-oxoproline in the urine, as well as a history of unexplained jaundice at birth and a history of chronic metabolic acidosis
Exclusion criteria included: Pregnancy, lactation, severe cardiovascular disease, having other infections such as human immunodeficiency virus (HIV), history of taking L-carnitine supplement in the last month, requires intensive care units (ICU), patients with high and critical disease severity, taking anti-inflammatory drugs out of the patient's medication regimen and the patient's unwillingness to continue cooperating with investigators
] In any discussion about the peptide BPC-157, oral vs injection is the one topic where people get heated
remains a significant hurdle, with retail list prices often exceeding $1,000 to $1,350 per month for those without coverage
People with variants in the SLC22A5 gene (often referred to as carnitine transporter deficiency) which results in carnitine deficiency can have skeletal myopathy and/or cardiomyopathy [7]